Medical Nitrous Oxide Market: Growth, Size, Share, and Trends

Medical Nitrous Oxide Market by Product (Gas, Liquid), Application (Anesthesia, Pain, Cryosurgery, Surgical Insufflation), End User (Hospital, Home healthcare, Academic, Research Institution), Key Stakeholder & Buying Criteria - Global Forecast to 2029

Report Code: MD 8935 Feb, 2024, by marketsandmarkets.com

Market Growth Outlook Summary

The global medical nitrous oxide market growth forecasted to transform from USD 1.8 Billion in 2023 to USD 2.8 Billion by 2029, driven by a CAGR of 6.6%. The primary impetus behind the market stems from various factors, including the expanding elderly population, improvements in healthcare infrastructure, the desire for non-invasive pain relief methods, and the presence of supportive regulations and standards governing the utilization of medical gases. Furthermore, the escalating volume of surgical procedures, observed in both developed and developing nations, creates a favorable prospect for the heightened adoption of medical nitrous oxide in anesthesia and analgesia, presenting additional avenues for industry expansion.

Global Medical Nitrous Oxide Market Trend

Nitrous Oxide Market

To know about the assumptions considered for the study, Request for Free Sample Report

Nitrous Oxide Market

Medical Nitrous Oxide Market Dynamics

Driver: Improvements in healthcare infrastructure

Enhancements in healthcare infrastructure serve as a catalyst for the growth of the market. The continuous improvement and development of healthcare facilities contribute significantly to the increased demand for medical nitrous oxide. This is attributed to the heightened capability of upgraded healthcare infrastructure to support advanced medical procedures, including surgeries and pain management, wherein nitrous oxide plays a crucial role. As healthcare systems evolve and modernize, the demand for medical nitrous oxide is expected to rise proportionately, aligning with the evolving needs and standards of sophisticated healthcare delivery.

Restraint: Availability of alternatives

The presence of alternative solutions poses a restraint to the market. The availability of other options for anesthesia and pain management in healthcare settings creates a competitive environment for medical nitrous oxide. Healthcare providers may opt for alternative methods based on factors such as patient preferences or specific medical requirements, impacting the market demand for nitrous oxide. This competition from alternative solutions represents a challenge for the widespread adoption of medical nitrous oxide in certain medical procedures.

Opportunity: Growing demand for pain management

The increasing demand for pain management presents a significant opportunity for the market. As the need for effective and non-invasive pain relief methods continues to grow, medical nitrous oxide stands poised to capitalize on this trend. The unique analgesic properties of nitrous oxide make it a valuable asset in pain management within healthcare settings. This rising demand positions medical nitrous oxide as a preferred choice for healthcare professionals seeking efficient solutions for pain relief, thereby contributing to the expansion and opportunities within the market.

Challenge: Limited awareness

Limited awareness poses a challenge to the market. The insufficient understanding and awareness among healthcare professionals and patients regarding the benefits and safety of nitrous oxide hinder its widespread adoption for medical and dental procedures. Overcoming this challenge requires targeted educational initiatives to enhance awareness and promote the advantages of using nitrous oxide in various healthcare settings. Increasing knowledge within the medical community and among patients is crucial for fostering greater acceptance and utilization of nitrous oxide, addressing the challenge of limited awareness in the market.

Ecosystem of Medical Nitrous Oxide Industry:

Nitrous Oxide Market Ecosystem

The gasesous segment of medical nitrous oxide industry is expected to account for the largest market share in 2023

In 2023, the medical nitrous oxide market experienced segmentation into gaseous and liquid states based on products, with the gaseous segment taking the lead. The prominence of the gaseous state within the market can be credited to its adaptability in various applications, notably for anesthesia and analgesia in surgical procedures. The inclination towards the gaseous form in medical settings is influenced by its easy administration, accurate dosage control, and rapid onset of action.

The anesthesia and pain relief segment of medical nitrous oxide industry to register the highest growth rate in the forecast period.

In 2023, the medical nitrous oxide market was classified into segments including anesthesia and pain relief, cryosurgery, and surgical insufflation. The anesthesia and pain relief segment emerged as the dominant category, holding the largest market share. The supremacy of anesthesia and pain relief applications within the market is ascribed to their pivotal roles in both surgical and medical procedures. Nitrous oxide, well-regarded for its anesthetic and analgesic properties, finds widespread adoption in healthcare settings due to its effectiveness in inducing conscious sedation and alleviating pain during various medical interventions. This dominance is evident in the extensive use of nitrous oxide by healthcare professionals, leveraging its ability to provide rapid and controllable sedation, thus significantly enhancing patient comfort and procedural success.

The home healthcare segment of medical nitrous oxide industry is expected to register the highest growth during the forecast period

The medical nitrous oxide market is classified by end user into hospitals, home healthcare, and academic and research institutions. As of 2023, the home healthcare segment is expected to register the highest growth during the forecast period . This is primarily due to evolving healthcare trends and an increasing preference for healthcare services delivered in the comfort of patients' homes. The demand for medical nitrous oxide in home healthcare settings is rising as it becomes a viable option for pain management and certain medical procedures outside traditional healthcare facilities. The convenience, flexibility, and personalized nature of home healthcare contribute to the substantial growth of the market within this particular segment.

North America to be the largest regional segment in the medical nitrous oxide industry during the forecast period.

Based on the region, the global medical nitrous oxide market is divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is expected to hold the largest share of the market in 2023. The Asia Pacific region is anticipated to experience the most rapid growth during the forecast period. The significant expansion of the market in the Asia Pacific can be attributed to the a rise in surgical procedures, dynamic growth in healthcare infrastructure, and an increasing awareness of the advantages of nitrous oxide. These factors collectively contribute to an increased demand for medical nitrous oxide in the APAC region.

Nitrous Oxide Market by Region

To know about the assumptions considered for the study, download the pdf brochure

The medical nitrous oxide market is dominated by a few globally established players such as Southern Gas Limited (India), Jiangsu Huazhong Gas Co., Ltd. (China), American Welding & Gas (US), Carbide and Chemicals (India), nexAir (US), Air Liquide (Paris), Linde plc (Ireland), Messer SE & CO. KGAA (Germany), SOL SpA (Italy), Chengdu Taiyu Industrial Gases Co., Ltd. (China),Oxygen & Argon Works Ltd (Israel), Matheson Tri-Gas Inc. (US), CalOx (US), Steelman Gases Pvt. Ltd. (India), Earlbeck Gases & Technology (US), Ellenbarrie Industrial Gases (India), Norco Inc. (US), and Gulf Cryo (UAE).

Scope of the Medical Nitrous Oxide Industry

Report Metric

Details

Market Revenue Size in 2023

$1.8 Billion

Projected Revenue Size by 2029

$2.8 Billion

Industry Growth Rate

Poised to Grow at a CAGR of 6.6%

Market Driver

Improvements in healthcare infrastructure

Market Opportunity

Growing demand for pain management

The study categorizes the medical nitrous oxide market to forecast revenue and analyze trends in each of the following submarkets:

By Product
  • Gaseous State
  • Liquid State
By Application
  • Anesthesia and Pain Relief
  • Cryosurgery
  • Surgical Insufflation
By End User
  • Hospitals
  • Home Healthcare
  • Academic & Research Institutions
By Region
  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Rest of Asia Pacific
  • Latin America
  • Middle East & Africa

Recent Developments of Medical Nitrous Oxide Industry:

  • In December 2023, Linde Healthcare has partnered with the Air Force Materiel Command to supply liquid oxygen and nitrogen to healthcare, manufacturing, metals, and mining.
  • In July 2023, Air liquid started a project to transform the Home Healthcare activity in France to align it with the needs and expectations of patients and healthcare professionals and adapt its business model to meet the challenges of the country's healthcare system.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

INTRODUCTION
21
RESEARCH METHODOLOGY
25
EXECUTIVE SUMMARY
39
PREMIUM INSIGHTS
42
MARKET OVERVIEW
45
  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    DRIVERS
    - Increasing number of surgeries and dental procedures
    - Growing adoption of nitrous oxide across various medical specialties
    - Rising geriatric population and subsequent increase in prevalence of chronic diseases
    - Growing demand for home healthcare
    RESTRAINTS
    - Potential risks associated with nitrous oxide misuse
    - Availability of alternatives
    OPPORTUNITIES
    - Rising demand for pain management
    - Technological advancements
    CHALLENGES
    - Changes in calibration standards
    - Lack of awareness
  • 5.3 INDUSTRY TRENDS
    ADVANCEMENTS IN NITROUS OXIDE DELIVERY SYSTEMS
    GROWING DEMAND FOR MINIMALLY INVASIVE PROCEDURES
  • 5.4 TECHNOLOGY ANALYSIS
    KEY TECHNOLOGIES
    - Nitrous oxide delivery systems
    - Monitoring and control systems
    - Technological integration in anesthesia machines
    COMPLEMENTARY TECHNOLOGIES
    - Patient monitoring devices
    - Smart devices and connectivity
    ADJACENT TECHNOLOGIES
    - Advanced anesthetic agents
    - Surgical robotics
  • 5.5 PRICING ANALYSIS
    AVERAGE SELLING PRICE TREND OF MEDICAL NITROUS OXIDE, BY PRODUCT
    AVERAGE SELLING PRICE TREND, BY REGION
  • 5.6 PORTER’S FIVE FORCES ANALYSIS
    INTENSITY OF COMPETITIVE RIVALRY
    BARGAINING POWER OF SUPPLIERS
    BARGAINING POWER OF BUYERS
    THREAT OF SUBSTITUTES
    THREAT OF NEW ENTRANTS
  • 5.7 TARIFF & REGULATORY ANALYSIS
    TARIFF FOR MEDICAL NITROUS OXIDE
    REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    NORTH AMERICA
    - US
    - Canada
    EUROPE
    ASIA PACIFIC
    - Japan
    - China
    - India
    LATIN AMERICA AND MIDDLE EAST & AFRICA
  • 5.8 VALUE CHAIN ANALYSIS
  • 5.9 ECOSYSTEM ANALYSIS
  • 5.10 CASE STUDY ANALYSIS
    CASE STUDY: EAST LANCASHIRE TEACHING HOSPITAL NHS FOUNDATION TRUST (ELHT)
  • 5.11 PATENT ANALYSIS
    PATENT PUBLICATION TRENDS
    JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR MEDICAL NITROUS OXIDE PATENTS (2014–2024)
    MEDICAL NITROUS OXIDE MARKET: TOP APPLICANTS
  • 5.12 KEY STAKEHOLDERS & BUYING CRITERIA
    KEY STAKEHOLDERS IN BUYING PROCESS
    BUYING CRITERIA
  • 5.13 KEY CONFERENCES & EVENTS IN 2024
  • 5.14 TRADE ANALYSIS
    TRADE ANALYSIS FOR MEDICAL NITROUS OXIDE
  • 5.15 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
  • 5.16 UNMET NEEDS ANALYSIS
    END-USER EXPECTATIONS
MEDICAL NITROUS OXIDE MARKET, BY TYPE
75
  • 6.1 INTRODUCTION
  • 6.2 LIQUID NITROUS OXIDE
    RISING CRYOTHERAPY APPLICATIONS TO DRIVE MARKET
  • 6.3 GASEOUS NITROUS OXIDE
    PRECISE DOSAGE CONTROL AND PORTABILITY TO DRIVE MARKET GROWTH
MEDICAL NITROUS OXIDE MARKET, BY APPLICATION
81
  • 7.1 INTRODUCTION
  • 7.2 ANESTHESIA & PAIN RELIEF
    WIDE USAGE AS CARRIER FOR OTHER ANESTHETIC GASES TO DRIVE MARKET
  • 7.3 CRYOSURGERY
    PAINLESSNESS OF CRYOSURGICAL PROCEDURES TO SUPPORT ADOPTION
  • 7.4 SURGICAL INSUFFLATION
    USE OF NITROUS OXIDE AS INSUFFLATION GAS IN LAPAROSCOPIC AND ENDOSCOPIC SURGERIES TO DRIVE MARKET
MEDICAL NITROUS OXIDE MARKET, BY END USER
89
  • 8.1 INTRODUCTION
  • 8.2 HOSPITALS
    EXTENSIVE USAGE OF MEDICAL NITROUS OXIDE TO DRIVE MARKET
  • 8.3 HOME CARE SETTINGS
    HOME CARE SETTINGS TO WITNESS HIGHEST GROWTH DUE TO RISING PREVALENCE OF CHRONIC DISEASES
  • 8.4 ACADEMIC & RESEARCH INSTITUTES
    COLLABORATION WITH INDUSTRY PARTNERS FOR TECHNOLOGICAL ADVANCES TO SUPPORT GROWTH
MEDICAL NITROUS OXIDE MARKET, BY REGION
97
  • 9.1 INTRODUCTION
  • 9.2 NORTH AMERICA
    NORTH AMERICA: RECESSION IMPACT
    US
    - US to dominate North American medical nitrous oxide market
    CANADA
    - Stringent regulatory compliance to support market growth in Canada
  • 9.3 EUROPE
    EUROPE: RECESSION IMPACT
    GERMANY
    - Increasing healthcare spending to drive market
    UK
    - Increasing surgeries & dental procedures to drive market
    FRANCE
    - Well-established healthcare system to drive market
    ITALY
    - Rapid growth in geriatric population and rising life expectancy to favor market growth
    SPAIN
    - Increasing prevalence of cancer to support market growth
    REST OF EUROPE
  • 9.4 ASIA PACIFIC
    ASIA PACIFIC: RECESSION IMPACT
    JAPAN
    - Japan to hold largest share of APAC market
    CHINA
    - Strong investments in infrastructural development to offer opportunities for market growth
    INDIA
    - Rising procedural volume to ensure sustained demand for medical gases
    REST OF ASIA PACIFIC
  • 9.5 LATIN AMERICA
    RISING PUBLIC-PRIVATE PARTNERSHIPS FOR HEALTHCARE DEVELOPMENT TO PROMOTE ADOPTION OF MEDICAL NITROUS OXIDE
    LATIN AMERICA: RECESSION IMPACT
  • 9.6 MIDDLE EAST & AFRICA
    GOVERNMENT INITIATIVES FOR INFRASTRUCTURAL DEVELOPMENT TO SUPPORT MARKET GROWTH
    MIDDLE EAST & AFRICA: RECESSION IMPACT
COMPETITIVE LANDSCAPE
144
  • 10.1 OVERVIEW
  • 10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
  • 10.3 REVENUE ANALYSIS
  • 10.4 MARKET SHARE ANALYSIS
  • 10.5 MARKET RANKING ANALYSIS
  • 10.6 COMPANY EVALUATION MATRIX: KEY PLAYERS
    STARS
    EMERGING LEADERS
    PERVASIVE PLAYERS
    PARTICIPANTS
    COMPANY FOOTPRINT
  • 10.7 COMPANY EVALUATION MATRIX: STARTUPS/SMES
    PROGRESSIVE COMPANIES
    RESPONSIVE COMPANIES
    DYNAMIC COMPANIES
    STARTING BLOCKS
    COMPETITIVE BENCHMARKING
    - Detailed list of key startups/SMEs
    - Competitive benchmarking of key startups/SMEs
  • 10.8 BRAND/PRODUCT COMPARISON
  • 10.9 COMPANY EVALUATION AND FINANCIAL METRICS
  • 10.10 COMPETITIVE SCENARIO
    DEALS
    EXPANSIONS
COMPANY PROFILES
164
  • 11.1 KEY PLAYERS
    AIR LIQUIDE
    - Business overview
    - Products offered
    - MnM view
    LINDE PLC
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    SOL SPA
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    TAIYO NIPPON SANSO CORPORATION
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    NORCO INC.
    - Business overview
    - Products offered
    - MnM view
    SOUTHERN GAS LIMITED
    - Business overview
    - Products offered
    ELLENBARRIE INDUSTRIAL GASES
    - Business overview
    - Products offered
    CALOX INC.
    - Business overview
    - Products offered
    STEELMAN GASES PVT. LTD.
    - Business overview
    - Products offered
    NEXAIR
    - Business overview
    - Products offered
    - Recent developments
    OXYGEN & ARGON WORKS LTD.
    - Business overview
    - Products offered
    GULFCRYO
    - Business overview
    - Products offered
    CHENGDU TAIYO INDUSTRIAL GASES CO., LTD.
    - Business overview
    - Products offered
    JIANGSU HUAZHONG GAS CO., LTD.
    - Business overview
    - Products offered
    CARBIDE AND CHEMICALS
    - Business overview
    - Products offered
    AMERICAN WELDING & GAS
    - Business overview
    - Products offered
    ASIA INDUSTRIAL GASES PTE. LTD.
    - Business overview
    - Products offered
    MIDDLESEX GASES & TECHNOLOGY INC.
    - Business overview
    - Products offered
    AMERITANX CYLINDERS
    - Business overview
    - Products offered
    CRYOCARB
    - Business overview
    - Products offered
  • 11.2 OTHER PLAYERS
    HOLSTON GASES
    AOPL
    BUTLER GAS PRODUCTS COMPANY
    GRUPPO SIAD
    ANDY OXY CO., INC.
APPENDIX
196
  • 12.1 DISCUSSION GUIDE
  • 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
  • 12.3 CUSTOMIZATION OPTIONS
  • 12.4 RELATED REPORTS
  • 12.5 AUTHOR DETAILS
LIST OF TABLES
 
  • TABLE 1 RISK ASSESSMENT: MEDICAL NITROUS OXIDE MARKET
  • TABLE 2 MARKET DYNAMICS: IMPACT ANALYSIS
  • TABLE 3 AVERAGE SELLING PRICE OF MEDICAL NITROUS OXIDE, BY PRODUCT TYPE (USD)
  • TABLE 4 PORTER’S FIVE FORCES ANALYSIS
  • TABLE 5 US: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 6 CANADA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 7 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES AND OTHER ORGANIZATIONS
  • TABLE 8 JAPAN: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 9 CHINA: STANDARDS FOR MEDICAL GAS EQUIPMENT
  • TABLE 10 CHINA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 11 INDIA: STANDARDS FOR MEDICAL GAS EQUIPMENT
  • TABLE 12 INDIA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 13 LATIN AMERICA AND MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 14 MEDICAL NITROUS OXIDE MARKET: ECOSYSTEM MAPPING
  • TABLE 15 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR MEDICAL NITROUS OXIDE PATENTS
  • TABLE 16 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR MEDICAL NITROUS OXIDE PRODUCTS
  • TABLE 17 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR MEDICAL NITROUS OXIDE END USERS
  • TABLE 18 KEY BUYING CRITERIA FOR MEDICAL NITROUS OXIDE MARKET
  • TABLE 19 MEDICAL NITROUS OXIDE MARKET: DETAILED LIST OF CONFERENCES & EVENTS
  • TABLE 20 UNMET NEEDS IN MEDICAL NITROUS OXIDE MARKET
  • TABLE 21 END-USER EXPECTATIONS IN MEDICAL NITROUS OXIDE MARKET
  • TABLE 22 MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2018–2021 (USD MILLION)
  • TABLE 23 MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 24 LIQUID MEDICAL NITROUS OXIDE MARKET, BY COUNTRY, 2018–2021 (USD MILLION)
  • TABLE 25 LIQUID MEDICAL NITROUS OXIDE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 26 GASEOUS MEDICAL NITROUS OXIDE MARKET, BY COUNTRY, 2018–2021 (USD MILLION)
  • TABLE 27 GASEOUS MEDICAL NITROUS OXIDE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 28 MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2018–2021 (USD MILLION)
  • TABLE 29 MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 30 MEDICAL NITROUS OXIDE MARKET FOR ANESTHESIA & PAIN RELIEF, BY COUNTRY, 2018–2021 (USD MILLION)
  • TABLE 31 MEDICAL NITROUS OXIDE MARKET FOR ANESTHESIA & PAIN RELIEF, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 32 MEDICAL NITROUS OXIDE MARKET FOR CRYOSURGERY, BY COUNTRY, 2018–2021 (USD MILLION)
  • TABLE 33 MEDICAL NITROUS OXIDE MARKET FOR CRYOSURGERY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 34 MEDICAL NITROUS OXIDE MARKET FOR SURGICAL INSUFFLATION, BY COUNTRY, 2018–2021 (USD MILLION)
  • TABLE 35 MEDICAL NITROUS OXIDE MARKET FOR SURGICAL INSUFFLATION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 36 MEDICAL NITROUS OXIDE MARKET, BY END USER, 2018–2021 (USD MILLION)
  • TABLE 37 MEDICAL NITROUS OXIDE MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 38 MEDICAL NITROUS OXIDE MARKET FOR HOSPITALS, BY COUNTRY, 2018–2021 (USD MILLION)
  • TABLE 39 MEDICAL NITROUS OXIDE MARKET FOR HOSPITALS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 40 MEDICAL NITROUS OXIDE MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2018–2021 (USD MILLION)
  • TABLE 41 MEDICAL NITROUS OXIDE MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 42 MEDICAL NITROUS OXIDE MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2018–2021 (USD MILLION)
  • TABLE 43 MEDICAL NITROUS OXIDE MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 44 MEDICAL NITROUS OXIDE MARKET, BY REGION, 2018–2021 (USD MILLION)
  • TABLE 45 MEDICAL NITROUS OXIDE MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 46 NORTH AMERICA: MEDICAL NITROUS OXIDE MARKET, BY COUNTRY, 2018–2021 (USD MILLION)
  • TABLE 47 NORTH AMERICA: MEDICAL NITROUS OXIDE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 48 NORTH AMERICA: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2018–2021 (USD MILLION)
  • TABLE 49 NORTH AMERICA: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 50 NORTH AMERICA: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2018–2021 (USD MILLION)
  • TABLE 51 NORTH AMERICA: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 52 NORTH AMERICA: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2018–2021 (USD MILLION)
  • TABLE 53 NORTH AMERICA: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 54 US: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2018–2021 (USD MILLION)
  • TABLE 55 US: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 56 US: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2018–2021 (USD MILLION)
  • TABLE 57 US: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 58 US: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2018–2021 (USD MILLION)
  • TABLE 59 US: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 60 CANADA: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2018–2021 (USD MILLION)
  • TABLE 61 CANADA: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 62 CANADA: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2018–2021 (USD MILLION)
  • TABLE 63 CANADA: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 64 CANADA: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2018–2021 (USD MILLION)
  • TABLE 65 CANADA: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 66 EUROPE: MEDICAL NITROUS OXIDE MARKET, BY COUNTRY, 2018–2021 (USD MILLION)
  • TABLE 67 EUROPE: MEDICAL NITROUS OXIDE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 68 EUROPE: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2018–2021 (USD MILLION)
  • TABLE 69 EUROPE: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 70 EUROPE: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2018–2021 (USD MILLION)
  • TABLE 71 EUROPE: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 72 EUROPE: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2018–2021 (USD MILLION)
  • TABLE 73 EUROPE: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 74 GERMANY: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2018–2021 (USD MILLION)
  • TABLE 75 GERMANY: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 76 GERMANY: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2018–2021 (USD MILLION)
  • TABLE 77 GERMANY: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 78 GERMANY: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2018–2021 (USD MILLION)
  • TABLE 79 GERMANY: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 80 UK: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2018–2021 (USD MILLION)
  • TABLE 81 UK: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 82 UK: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2018–2021 (USD MILLION)
  • TABLE 83 UK: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 84 UK: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2018–2021 (USD MILLION)
  • TABLE 85 UK: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 86 FRANCE: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2018–2021 (USD MILLION)
  • TABLE 87 FRANCE: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 88 FRANCE: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2018–2021 (USD MILLION)
  • TABLE 89 FRANCE: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 90 FRANCE: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2018–2021 (USD MILLION)
  • TABLE 91 FRANCE: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 92 ITALY: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2018–2021 (USD MILLION)
  • TABLE 93 ITALY: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 94 ITALY: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2018–2021 (USD MILLION)
  • TABLE 95 ITALY: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 96 ITALY: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2018–2021 (USD MILLION)
  • TABLE 97 ITALY: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 98 SPAIN: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2018–2021 (USD MILLION)
  • TABLE 99 SPAIN: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 100 SPAIN: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2018–2021 (USD MILLION)
  • TABLE 101 SPAIN: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 102 SPAIN: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2018–2021 (USD MILLION)
  • TABLE 103 SPAIN: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 104 REST OF EUROPE: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2018–2021 (USD MILLION)
  • TABLE 105 REST OF EUROPE: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 106 REST OF EUROPE: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2018–2021 (USD MILLION)
  • TABLE 107 REST OF EUROPE: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 108 REST OF EUROPE: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2018–2021 (USD MILLION)
  • TABLE 109 REST OF EUROPE: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 110 ASIA PACIFIC: MEDICAL NITROUS OXIDE MARKET, BY COUNTRY, 2018–2021 (USD MILLION)
  • TABLE 111 ASIA PACIFIC: MEDICAL NITROUS OXIDE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 112 ASIA PACIFIC: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2018–2021 (USD MILLION)
  • TABLE 113 ASIA PACIFIC: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 114 ASIA PACIFIC: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2018–2021 (USD MILLION)
  • TABLE 115 ASIA PACIFIC: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 116 ASIA PACIFIC: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2018–2021 (USD MILLION)
  • TABLE 117 ASIA PACIFIC: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 118 JAPAN: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2018–2021 (USD MILLION)
  • TABLE 119 JAPAN: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 120 JAPAN: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2018–2021 (USD MILLION)
  • TABLE 121 JAPAN: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 122 JAPAN: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2018–2021 (USD MILLION)
  • TABLE 123 JAPAN: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 124 CHINA: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2018–2021 (USD MILLION)
  • TABLE 125 CHINA: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 126 CHINA: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2018–2021 (USD MILLION)
  • TABLE 127 CHINA: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 128 CHINA: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2018–2021 (USD MILLION)
  • TABLE 129 CHINA: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 130 INDIA: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2018–2021 (USD MILLION)
  • TABLE 131 INDIA: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 132 INDIA: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2018–2021 (USD MILLION)
  • TABLE 133 INDIA: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 134 INDIA: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2018–2021 (USD MILLION)
  • TABLE 135 INDIA: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 136 REST OF ASIA PACIFIC: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2018–2021 (USD MILLION)
  • TABLE 137 REST OF ASIA PACIFIC: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 138 REST OF ASIA PACIFIC: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2018–2021 (USD MILLION)
  • TABLE 139 REST OF ASIA PACIFIC: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 140 REST OF ASIA PACIFIC: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2018–2021 (USD MILLION)
  • TABLE 141 REST OF ASIA PACIFIC: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 142 LATIN AMERICA: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2018–2021 (USD MILLION)
  • TABLE 143 LATIN AMERICA: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 144 LATIN AMERICA: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2018–2021 (USD MILLION)
  • TABLE 145 LATIN AMERICA: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 146 LATIN AMERICA: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2018–2021 (USD MILLION)
  • TABLE 147 LATIN AMERICA: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 148 MIDDLE EAST & AFRICA: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2018–2021 (USD MILLION)
  • TABLE 149 MIDDLE EAST & AFRICA: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 150 MIDDLE EAST & AFRICA: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2018–2021 (USD MILLION)
  • TABLE 151 MIDDLE EAST & AFRICA: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 152 MIDDLE EAST & AFRICA: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2018–2021 (USD MILLION)
  • TABLE 153 MIDDLE EAST & AFRICA: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 154 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN MEDICAL NITROUS OXIDE MARKET
  • TABLE 155 MEDICAL NITROUS OXIDE MARKET: DEGREE OF COMPETITION
  • TABLE 156 MEDICAL NITROUS OXIDE MARKET: TYPE FOOTPRINT
  • TABLE 157 MEDICAL NITROUS OXIDE MARKET: APPLICATION FOOTPRINT
  • TABLE 158 MEDICAL NITROUS OXIDE MARKET: END-USER FOOTPRINT
  • TABLE 159 MEDICAL NITROUS OXIDE MARKET: REGIONAL FOOTPRINT
  • TABLE 160 MEDICAL NITROUS OXIDE: DETAILED LIST OF KEY STARTUPS/SMES
  • TABLE 161 MEDICAL NITROUS OXIDE: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
  • TABLE 162 MEDICAL NITROUS OXIDE MARKET: DEALS, JANUARY 2020– JANUARY 2024
  • TABLE 163 MEDICAL NITROUS OXIDE MARKET: EXPANSIONS, JANUARY 2020–JANUARY 2024
  • TABLE 164 AIR LIQUIDE: COMPANY OVERVIEW
  • TABLE 165 LINDE PLC: COMPANY OVERVIEW
  • TABLE 166 SOL SPA: COMPANY OVERVIEW
  • TABLE 167 TAIYO NIPPON SANSO CORPORATION: COMPANY OVERVIEW
  • TABLE 168 NORCO INC.: COMPANY OVERVIEW
  • TABLE 169 SOUTHERN GAS LIMITED: COMPANY OVERVIEW
  • TABLE 170 ELLENBARRIE INDUSTRIAL GASES: COMPANY OVERVIEW
  • TABLE 171 CALOX INC.: COMPANY OVERVIEW
  • TABLE 172 STEELMAN GASES PVT. LTD.: COMPANY OVERVIEW
  • TABLE 173 NEXAIR: COMPANY OVERVIEW
  • TABLE 174 OXYGEN & ARGON WORKS LTD.: COMPANY OVERVIEW
  • TABLE 175 GULFCRYO: COMPANY OVERVIEW
  • TABLE 176 CHENGDU TAIYO INDUSTRIAL GASES CO. LTD.: COMPANY OVERVIEW
  • TABLE 177 JIANGSU HAUZHONG GAS CO., LTD.: COMPANY OVERVIEW
  • TABLE 178 CARBIDE AND CHEMICALS: COMPANY OVERVIEW
  • TABLE 179 AMERICAN WELDING & GAS: COMPANY OVERVIEW
  • TABLE 180 ASIA INDUSTRIAL GASES PTE. LTD.: COMPANY OVERVIEW
  • TABLE 181 MIDDLESEX GASES & TECHNOLOGIES INC.: COMPANY OVERVIEW
  • TABLE 182 AMERITANX CYLINDERS: COMPANY OVERVIEW
  • TABLE 183 CRYOCARB: COMPANY OVERVIEW
LIST OF FIGURES
 
  • FIGURE 1 MEDICAL NITROUS OXIDE MARKET SEGMENTATION
  • FIGURE 2 RESEARCH DESIGN
  • FIGURE 3 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
  • FIGURE 4 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
  • FIGURE 5 MEDICAL NITROUS OXIDE MARKET: REVENUE SHARE ANALYSIS ILLUSTRATION FOR AIR LIQUIDE S.A.
  • FIGURE 6 MEDICAL NITROUS OXIDE MARKET: DEMAND-SIDE MODELING
  • FIGURE 7 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN MEDICAL NITROUS OXIDE MARKET (2023–2029)
  • FIGURE 8 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
  • FIGURE 9 DATA TRIANGULATION METHODOLOGY
  • FIGURE 10 MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2023 VS. 2029 (USD MILLION)
  • FIGURE 11 MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2023 VS. 2029 (USD MILLION)
  • FIGURE 12 MEDICAL NITROUS OXIDE MARKET, BY END USER, 2023 VS. 2029 (USD MILLION)
  • FIGURE 13 GEOGRAPHICAL SNAPSHOT OF MEDICAL NITROUS OXIDE MARKET
  • FIGURE 14 INCREASING NUMBER OF SURGERIES AND DENTAL PROCEDURES TO DRIVE MARKET GROWTH
  • FIGURE 15 LIQUID NITROUS OXIDE SEGMENT ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN MARKET IN 2022
  • FIGURE 16 ASIA PACIFIC REGION TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
  • FIGURE 17 ASIA PACIFIC MARKET TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
  • FIGURE 18 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD
  • FIGURE 19 MEDICAL NITROUS OXIDE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 20 GLOBAL GERIATRIC POPULATION, BY REGION, 2010–2030 (% OF TOTAL POPULATION)
  • FIGURE 21 PREVALENCE OF CHRONIC PAIN AND HIGH-IMPACT CHRONIC PAIN AMONG ADULTS IN US, 2019–2021
  • FIGURE 22 VALUE CHAIN ANALYSIS
  • FIGURE 23 MEDICAL NITROUS OXIDE MARKET: ECOSYSTEM
  • FIGURE 24 PATENT PUBLICATION TRENDS, 2014–2024
  • FIGURE 25 TOP APPLICANTS FOR MEDICAL NITROUS OXIDE PATENTS (2014–2024)
  • FIGURE 26 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS
  • FIGURE 27 KEY BUYING CRITERIA FOR END USERS IN MEDICAL NITROUS OXIDE MARKET
  • FIGURE 28 PRODUCT IMPORTS UNDER HSN CODE 281129, BY COUNTRY, 2022 (USD THOUSAND)
  • FIGURE 29 PRODUCT EXPORTS UNDER HSN CODE 281129, BY COUNTRY, 2022 (USD THOUSAND)
  • FIGURE 30 REVENUE SHIFT IN MEDICAL NITROUS OXIDE MARKET
  • FIGURE 31 NORTH AMERICA: MEDICAL NITROUS OXIDE MARKET SNAPSHOT
  • FIGURE 32 ASIA PACIFIC: MEDICAL NITROUS OXIDE MARKET SNAPSHOT
  • FIGURE 33 REVENUE ANALYSIS OF KEY PLAYERS IN MEDICAL NITROUS OXIDE MARKET, 2018–2022 (USD MILLION)
  • FIGURE 34 MEDICAL NITROUS OXIDE MARKET SHARE ANALYSIS (2022)
  • FIGURE 35 MEDICAL NITROUS OXIDE MARKET RANKING, BY KEY PLAYER, 2022
  • FIGURE 36 MEDICAL NITROUS OXIDE MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
  • FIGURE 37 MEDICAL NITROUS OXIDE MARKET: COMPANY FOOTPRINT
  • FIGURE 38 MEDICAL NITROUS OXIDE MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
  • FIGURE 39 EV/EBITDA OF KEY VENDORS
  • FIGURE 40 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF MEDICAL NITROUS OXIDE VENDORS
  • FIGURE 41 AIR LIQUIDE: COMPANY SNAPSHOT (2022)
  • FIGURE 42 LINDE PLC: COMPANY SNAPSHOT (2022)
  • FIGURE 43 SOL SPA: COMPANY SNAPSHOT (2022)
  • FIGURE 44 TAIYO NIPPON SANSO CORPORATION: COMPANY SNAPSHOT (2023)
  • FIGURE 45 SOUTHERN GAS LIMITED: COMPANY SNAPSHOT (2022)
  • FIGURE 46 ELLENBARRIE INDUSTRIAL GASES: COMPANY SNAPSHOT (2020)

The study involved four major activities in estimating the current size of the medical nitrous oxide market. Exhaustive secondary research was done to collect information on the market and its different sub-segments. The next step was to validate these findings, assumptions, and market sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate the market size of the segments and sub-segments.

Secondary Research

This research study involved the extensive usage of secondary sources; directories; databases such as Bloomberg Business, Factiva, and Wall Street Journal; white papers and annual reports; company house documents; investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the brain monitoring market. It was also used to obtain important information about the key market players, market classification & segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

Primary Research

In the primary research process, various primary sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information important for this report. Primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing directors, technology and innovation directors, and related executives from various key companies and organizations operating in the medical nitrous oxide market. After the complete market engineering process (which includes calculations for market statistics, market breakdown, market size estimations, market forecasting, and data triangulation), extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at.

Some of the major objectives of primary research are:

  • To validate market segmentation defined through an assessment of the product portfolios of leading players
  • To understand the key industry trends and technologies defining the strategic growth objectives of market players
  • To gather both demand- and supply-side validation of the key factors affecting the market growth
  • To validate assumptions for the market sizing and forecasting model used for this study
  • To understand the market position of leading players in the medical nitrous oxide market and their market share/ranking

Breakdown Of Primary Participants

Nitrous Oxide Market Size, and Share

*Others include sales managers, marketing managers, and product managers.

Note: Tiers are defined based on a company’s total revenue. As of 2023, Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = <USD 500 million.

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Top-down approach used to estimate and validate the total size of the Medical nitrous oxide market. This methods were also used extensively to estimate the size of various subsegments in the market.

Top-down approach

The overall medical nitrous oxide market size was used in the top-down approach to estimate the sizes of other individual markets (mentioned in the market segmentation by product, application, end user, and region) through percentage splits from secondary and primary research.

For the calculation of each type of specific market segment, the most appropriate immediate-parent market size was used for implementing the top-down approach. The bottom-up approach was also implemented (wherever applicable) for data extracted from secondary research to validate the market segment revenues obtained. Market shares were then estimated for top companies to verify the total market revenue arrived earlier in the bottom-up approach.

Nitrous Oxide Market Size, and Share

To know about the assumptions considered for the study, Request for Free Sample Report

Data Triangulation

After arriving at the overall market size, from the market size estimation process explained above, the medical nitrous oxide market was split into segments and subsegments. To complete the overall market engineering process and to arrive at the exact statistics for all segments and subsegments, the data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the medical nitrous oxide industry.

Market Definition

Medical nitrous oxide is a pharmaceutical-grade, colorless, and odorless gas widely employed in healthcare settings for its anesthetic and analgesic properties. It is utilized as a medical gas in controlled environments, primarily in hospitals and dental clinics, to induce conscious sedation and alleviate pain during various medical procedures. Medical nitrous oxide is administered through specialized delivery systems to ensure precise dosage control, providing healthcare professionals with a reliable means of managing patient comfort and facilitating effective anesthesia.

Key Stakeholders

  • World Health Organization (WHO)
  • National Center for Biotechnology Information (NCBI)
  • Centers for Disease Control and Prevention (CDC)
  • US Food and Drug Administration (FDA)
  • Drug Enforcement Administration (DEA)
  • European Medicines Agency (EMA)
  • Compressed Gas Association (CGA)
  • American Society of Anesthesiologists (ASA)

Report Objectives

  • To define, describe, and forecast the medical nitrous oxide market based on the product, application, end user, and region
  • To provide detailed information regarding the major factors influencing the growth of the market (such as drivers, restraints, opportunities, and challenges)
  • To strategically analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall medical nitrous oxide market
  • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To profile the key players in the market and comprehensively analyze their market shares and core competencies2
  • To forecast the size of the market segments with respect to four main regions, namely, North America, Asia Pacific, Europe, Latin America, and Middle East & Africa.
  • To track and analyze competitive developments such as new product launches, agreements, collaborations, and expansions.

Available Customizations:

MarketsandMarkets offers the following customizations for this market report:

Company Information

  • Profiling of additional market players (up to 3)
Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Request Customization
Report Code
MD 8935
Published ON
Feb, 2024
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Medical Nitrous Oxide Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
knowledgestore logo

Want to explore hidden markets that can drive new revenue in Medical Nitrous Oxide Market?

Find Hidden Markets
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2024 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status
Website Feedback